Whiteley MS, Taylor LK, King JC, Hughes BE. Clinical dilemma of management: Cardiac arrest after microsclerotherapy for lower limb telangiectasia with liquid 0.3% aethoxysklerol or idiopathic cardiac arrest?
SAGE Open Med Case Rep 2021;
9:2050313X211000866. [PMID:
33786187 PMCID:
PMC7958149 DOI:
10.1177/2050313x211000866]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2021] [Accepted: 02/17/2021] [Indexed: 11/15/2022] Open
Abstract
A 48-year-old woman attended to discuss a dilemma. She had suffered a cardiac arrest
immediately following microsclerotherapy of leg telangiectasia with 0.3% aethoxysklerol.
She had successful defibrillation and been transferred to hospital. In hospital, despite
normal cardiac tests, she was diagnosed as having idiopathic cardiac arrest. The exposure
to aethoxysklerol was discounted by her cardiologists as a cause of her arrest. Following
the hospital protocol, she was strongly advised to have an implantable defibrillator.
Cardiac arrest and myocardial infarction are documented after aethoxysklerol injection
with proposed mechanisms being anaphylaxis, direct cardiotoxicity or endothelin-1 release.
Before consenting to an implantable defibrillator, which may have its own complications in
the long term, doctors and the patient need to be certain that this arrest was not due to
a reaction to aethoxysklerol.
Collapse